Anmol Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Anmol Chemicals And Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amir Kamdar, Anmol Kamdar, and Sujit Kumar serve as directors at the Company.
- CIN/LLPIN
U24299MH2022PTC375860
- Company No.
375860
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anmol Chemicals And Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amir Kamdar  | Director | 10-May-2022 | Current |
| Anmol Kamdar | Director | 01-Feb-2022 | Current |
| Sujit Kumar | Director | 26-Sep-2023 | Current |
Financial Performance of Anmol Chemicals And Pharmaceuticals.
Enhance accessibility to Anmol Chemicals And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anmol Chemicals And Pharmaceuticals?
Unlock access to Anmol Chemicals And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ana Industries Private LimitedActive 10 years 2 monthsAmir Kamdar and Anmol Kamdar are mutual person
Anmol Chemicals Industries Private LimitedActive 3 years 5 monthsAmir Kamdar, Anmol Kamdar and 1 more are mutual person
- Anmol Chemicals Private LimitedActive 1 year 11 months
Amir Kamdar, Anmol Kamdar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anmol Chemicals And Pharmaceuticals?
Anmol Chemicals And Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anmol Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anmol Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
